Holmusk, a trailblazer in the field of data analytics and health technology, recently announced a significant funding milestone, successfully raising $45 million. This injection of capital will be instrumental in furthering Holmusk鈥檚 mission to harness real-world evidence to transform both research and care in the behavioral health arena. Established in 2015 and with dual headquarters in Singapore and New York, Holmusk is at the forefront of innovation, combining a leading behavioral health database with AI-powered analytics and digital solutions tailored to address the most pressing challenges faced in the sector. With its flagship offerings, such as the HolCare EHR+ platform which integrates measurement-based care directly into electronic health records, and NeuroBlu Research, a cutting-edge data analytics tool designed to enable deeper explorations of patient cohorts and datasets, Holmusk is redefining how behavioral health data is utilized. This recent funding will not only bolster the development of these groundbreaking solutions but also expand their reach to improve patient outcomes on a global scale. Recognized as a Technology Pioneer by the World Economic Forum in 2019, Holmusk is poised for transformative growth as it continues to innovate and bridge gaps in behavioral health research and care. The company鈥檚 commitment to using data for the greater good has never been more relevant, and with this new funding, Holmusk is all set to lead the charge in shaping the future of mental health care.
Health Tech Innovator Holmusk Secures $45M in Series B Funding
Recently funded 路 $45.0M Series bHealthcare
Get the full Holmusk company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
